Pictet Asset Management (UK)’s Immunogen Inc IMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
$106K Hold
16,100
﹤0.01% 1700
2021
Q1
$130K Hold
16,100
﹤0.01% 1730
2020
Q4
$104K Hold
16,100
﹤0.01% 1695
2020
Q3
$58K Buy
+16,100
New +$65K ﹤0.01% 1532
2014
Q4
Sell
-157,150
Closed -$1.66M 898
2014
Q3
$1.66M Sell
157,150
-47,000
-23% -$532K 0.01% 759
2014
Q2
$2.42M Sell
204,150
-2,800
-1% -$35.1K 0.01% 712
2014
Q1
$3.09M Sell
206,950
-10,400
-5% -$164K 0.02% 655
2013
Q4
$3.19M Buy
217,350
+15,700
+8% +$241K 0.02% 634
2013
Q3
$3.43M Buy
201,650
+5,050
+3% +$88.8K 0.02% 616
2013
Q2
$3.26M Buy
+196,600
New +$3.19M 0.02% 600

Other funds holding IMGN

Pictet Asset Management (UK)'s IMGN Position: Q2 2021 in Review

Pictet Asset Management (UK) held its Immunogen Inc (IMGN) position steady in Q2 2021 at 16,100 shares worth $106K. The position accounts for ﹤0.01% of the portfolio, ranked #1700.

Pictet Asset Management (UK) first reported a position in IMGN in Q2 2013 and has held it in 10 quarters since. The position peaked at $3.43M in Q3 2013. 214 funds tracked by Wall St. Rank hold IMGN as of Q2 2021.

  • Pictet Asset Management (UK) held 16,100 shares of Immunogen Inc worth $106K as of Q2 2021.
  • Pictet Asset Management (UK) left its Immunogen Inc share count unchanged in Q2 2021.
  • Immunogen Inc made up ﹤0.01% of Pictet Asset Management (UK)'s portfolio in Q2 2021, its #1700 holding.
  • Pictet Asset Management (UK) first reported a position in Immunogen Inc in Q2 2013 and has held it in 10 quarters since.
  • Pictet Asset Management (UK)'s Immunogen Inc position peaked at $3.43M in Q3 2013.
  • 214 funds tracked by Wall St. Rank held Immunogen Inc as of Q2 2021.

Based on Pictet Asset Management (UK)'s 13F filing for Q2 2021, filed 16 Aug 2021.